New drug trial aims to stop liver Cancer's return after surgery
Disease control
Terminated
This study tested whether a drug called cadonilimab could help prevent liver cancer from coming back after successful surgery. It focused on patients at high risk of their cancer returning. The trial was terminated early and enrolled 45 participants to assess safety and effective…
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC